These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18721333)

  • 1. Candida infection in HIV positive patients 1985-2007.
    Traeder C; Kowoll S; Arastéh K
    Mycoses; 2008 Sep; 51 Suppl 2():58-61. PubMed ID: 18721333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
    Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
    Yang YL; Lo HJ; Hung CC; Li Y
    BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infections by Candida and cryptococci].
    Berenguer J; Blázquez R; Ocaña I; Lozano F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():29-35. PubMed ID: 9859617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.
    Fichtenbaum CJ; Koletar S; Yiannoutsos C; Holland F; Pottage J; Cohn SE; Walawander A; Frame P; Feinberg J; Saag M; Van der Horst C; Powderly WG
    Clin Infect Dis; 2000 May; 30(5):749-56. PubMed ID: 10816143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA
    HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
    Blignaut E; Botes ME; Nieman HL
    SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [For oral candidiasis and co. Fluconazole remains in the forefront].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():90. PubMed ID: 15373066
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics.
    Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP
    Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral candidiasis in HIV-infected patients.
    Brawner DL; Hovan AJ
    Curr Top Med Mycol; 1995; 6():113-25. PubMed ID: 8724244
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
    Le TP; Tuazon CU; Levine M; Borum M; Rollhauser C
    Clin Infect Dis; 1996 Sep; 23(3):649-50. PubMed ID: 8879803
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.
    Ng TT; Denning DW
    J Infect; 1993 Mar; 26(2):117-25. PubMed ID: 8473758
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of fungal organisms in saliva from HIV-infected children: a preliminary cytologic analysis.
    Hicks MJ; Carter AB; Rossmann SN; Demmler GJ; Simon CL; Cron SG; Flaitz CM; Shearer WT; Kline MW
    Pediatr Dent; 1998; 20(3):162-8. PubMed ID: 9635310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fluconazole in the treatment of esophageal, bronchial and oral candidiasis in patients with ARC and AIDS].
    Gritti FM; Raise E; Di Salvo S; Vannini V; Lanzoni G; Cucci AM
    G Ital Chemioter; 1988; 35(1-3):61-8. PubMed ID: 2855730
    [No Abstract]   [Full Text] [Related]  

  • 17. Decline in esophageal candidiasis and use of antimycotics in European patients with HIV.
    Mocroft A; Oancea C; van Lunzen J; Vanhems P; Banhegyi D; Chiesi A; Vinogradova E; Maayan S; Phillips AN; Lundgren J;
    Am J Gastroenterol; 2005 Jul; 100(7):1446-54. PubMed ID: 15984964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.
    Hood S; Bonington A; Evans J; Denning D
    AIDS; 1998 Mar; 12(4):447-8. PubMed ID: 9520182
    [No Abstract]   [Full Text] [Related]  

  • 19. [Candida albicans morphotypes and in vitro adhesivity to cells of the human oral mucosa in HIV-positive and AIDS patients after exposure of blastospores to fluconazole. II].
    Spadari E; Arosio M; Malighetti V; Bellotti MG; Artini MZ; Spadari F; Riviera L
    Minerva Stomatol; 1998; 47(7-8):293-7. PubMed ID: 9793362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy.
    Powderly WG; Gallant JE; Ghannoum MA; Mayer KH; Navarro EE; Perfect JR
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1619-23. PubMed ID: 10606084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.